Tonix Pharmaceuticals (TNXP)
(Delayed Data from NSDQ)
$1.09 USD
-0.02 (-1.80%)
Updated Jun 13, 2024 03:59 PM ET
Pre-Market: $1.23 +0.14 (12.84%) 8:10 AM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Tonix Pharmaceuticals Holding Corp. [TNXP]
Reports for Purchase
Showing records 121 - 140 ( 154 total )
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Physician Call Highlights Promise of TNX-102 SL
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
1Q14 Recap - Fibromyalgia Data Coming in Early 4Q14
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: NAPODANO J
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: NAPODANO J
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Depressed Valuation, Plus Catalysts, Could Drive Upside
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: NAPODANO J
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Raising PT to Reflect Lower Dilution and Emergence of Expanded Pipeline
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.